Title:
カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体及びその使用方法
Document Type and Number:
Japanese Patent JP6568099
Kind Code:
B2
Abstract:
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
More Like This:
| WO/2016/146587 | HEPCIDIN ANTAGONISTS FOR USE IN THE TREATMENT OF INFLAMMATION |
| WO/2013/179302 | ORAL ANTI-INFLAMMATORY FORMULATION COMPRISING POTENTISED CYTOKINE |
| WO/2009/090268 | PEPTIDE MIMETICS |
Inventors:
Bigal, marcelo
Sarah, Walter
Stern, henry
Chan, Michael
Sarah, Walter
Stern, henry
Chan, Michael
Application Number:
JP2016558395A
Publication Date:
August 28, 2019
Filing Date:
March 20, 2015
Export Citation:
Assignee:
Teva Pharmaceuticals International GmbH
International Classes:
A61K39/395; A61K9/08; A61K31/437; A61K45/00; A61P25/04; A61P25/06; C07K16/26
Domestic Patent References:
| JP5123197B2 | ||||
| JP2011513387A | ||||
| JP2011046710A |
Other References:
CNS Drugs, 2014 Mar 18, Vol.28, p.389-399
Cephalagia, 2014 June, Vol.34 No.7, p.483-492
Cephalagia, 2014 June, Vol.34 No.7, p.483-492
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe